NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue ...

The Delaware Supreme Court’s ruling in Cantor Fitzgerald v. Ainslie, which reversed the Court of Chancery’s 2023 finding ...

Cantor Fitzgerald currently has a “Overweight” rating and a $9.00 target price on the stock. The consensus estimate for Prenetics Global’s current full-year earnings is ($3.30) per share ...

Western Digital which will be splitting its business by the end of February remains confident to benefit from the rising AI ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – Cantor Fitzgerald issued their FY2025 earnings estimates for Arcturus Therapeutics in a report released on Tuesday ...

Billionaire financier Howard Lutnick, President Donald Trump’s choice to lead the Commerce Department, said Wednesday that he ...

Cantor Fitzgerald analyst Jonathan Ruykhaver reiterated a Hold rating on Check Point (CHKP – Research Report) today and set a price target of $200.00. The company’s shares closed last Friday ...

This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...

Cantor Fitzgerald analyst Jonathan Ruykhaver tells investors that the firm’s checks on Check Point (CHKP) remain consistent and “encouraging,” suggesting improved near-term performance.

In preparation for the launch, Cantor Fitzgerald hosted a discussion with a Senior Director of Product Development at UnitedHealth (NYSE:UNH). The conversation provided insights into the coverage ...